Filing Details

Accession Number:
0001513908-14-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-22 18:20:35
Reporting Period:
2014-04-17
Filing Date:
2014-04-22
Accepted Time:
2014-04-22 18:20:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1122388 Ellie Mae Inc ELLI Services-Prepackaged Software (7372) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1513908 Sigmund Anderman C/O Ellie Mae, Inc.
4155 Hopyard Road, Suite 200
Pleasanton CA 94588
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-04-17 5,000 $8.85 250,000 No 4 M Direct
Common Stock Disposition 2014-04-17 5,000 $25.33 245,000 No 4 S Direct
Common Stock Acquisiton 2014-04-21 5,000 $8.85 250,000 No 4 M Direct
Common Stock Disposition 2014-04-21 5,000 $25.22 245,000 No 4 S Direct
Common Stock Disposition 2014-04-22 13,750 $25.06 231,250 No 4 D Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 D Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-04-17 5,000 $0.00 5,000 $8.85
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-04-21 5,000 $0.00 5,000 $8.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,836 2020-08-26 No 4 M Direct
5,836 2020-08-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,000 Indirect by 401(k) Plan
Common Stock 399,841 Indirect by Trust
Footnotes
  1. The exercise and sale of these stock options was completed pursuant to the Rule 10b5-1 trading plan adopted by Sigmund Anderman.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. Reflects shares of common stock issued and sold in connection with the Compensation Committee of the Board of Directors certification on March 20, 2014 of the achievement of performance goals under the 2013 performance share awards. 25% of the total shares awarded were issued as fully vested shares on or about April 21, 2014. An additional 25% of the total shares awarded will vest on each of March 20, 2015, March 20, 2016, and March 20, 2017, subject to continuous service through such dates.
  4. Option vests with respect to 25% of the shares subject thereto on August 26, 2011, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on August 26, 2014.
  5. The reported transaction is a grant of a derivative security, in which we have left column 8 blank, and have reported the exercise or conversion price of the derivative security in column 2.